These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6178556)

  • 1. A stable TCGF-producing T cell hybridoma and its thioguanine-resistant variant suitable as a tool for the construction of new functional T hybridomas.
    Grönvik KO; Andersson J; Melchers F; Zeuthen J
    Curr Top Microbiol Immunol; 1982; 100():143-51. PubMed ID: 6178556
    [No Abstract]   [Full Text] [Related]  

  • 2. Production of antigen-nonspecific immunoregulatory lymphokines by T cell hybridomas.
    Altman A; Schreiber RD; Katz DH
    Curr Top Microbiol Immunol; 1982; 100():179-90. PubMed ID: 6178557
    [No Abstract]   [Full Text] [Related]  

  • 3. Constitutive and mitogen-induced production of T cell growth factor by stable T cell hybridoma lines.
    Altman A; Sferruzza A; Weiner RG; Katz DH
    J Immunol; 1982 Mar; 128(3):1365-71. PubMed ID: 6120196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A "Panreactive" T cell hybridoma which produces TCGF constitutively.
    Corbel C; Andersson J; Melchers F; Zeuthen J
    Curr Top Microbiol Immunol; 1982; 100():173-8. PubMed ID: 6980092
    [No Abstract]   [Full Text] [Related]  

  • 5. Lymphokine production by human T cell hybridomas.
    Le J; Vilcek J; Sadlik JR; Cheung MK; Balazs I; Sarngadharan MG; Prensky W
    J Immunol; 1983 Mar; 130(3):1231-5. PubMed ID: 6401782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characteristics of T cell hybridomas obtained by fusion of TCGF-dependent helper T cell clones with BW5147.
    Schreier MH; Tees R; Nordin L; Nordin AA
    Curr Top Microbiol Immunol; 1982; 100():135-41. PubMed ID: 6807607
    [No Abstract]   [Full Text] [Related]  

  • 7. Different factors active in lymphoid and hematopoietic proliferation produced by single clones of helper T cell hybridomas.
    Corbel C
    Curr Top Microbiol Immunol; 1982; 100():231-7. PubMed ID: 6980095
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of T cell hybridomas in the biochemical and biological characterization of multiple regulatory factors produced by T cells.
    Schrader JW; Clark-Lewis I
    Curr Top Microbiol Immunol; 1982; 100():221-9. PubMed ID: 6124369
    [No Abstract]   [Full Text] [Related]  

  • 9. Human cell lines secreting lymphokines. I. Establishment of T-T hybridomas.
    Epstein N; Gozes Y; Halmann M; Kobiler D
    Dev Biol Stand; 1987; 66():439-46. PubMed ID: 3108054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoid differentiation in vitro.
    Schrader JW; Bartlett PF; Clark-Lewis I; Boyd AW
    Ciba Found Symp; 1981; 84():130-60. PubMed ID: 7023867
    [No Abstract]   [Full Text] [Related]  

  • 11. Partial purification and characterization of B cell growth factor constitutively secreted by human T-cell hybridoma.
    Pathak SK; Tsang KY; Cathcart MK; Arnaud P; Boutin B; Fudenberg HH
    Immunol Lett; 1985; 10(6):339-46. PubMed ID: 3930398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a T cell hybridoma that produces large quantities of macrophage-activating factor.
    Schreiber RD; Altman A; Katz DH
    J Exp Med; 1982 Sep; 156(3):677-89. PubMed ID: 7050288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The AKR thymoma BW5147 is able to produce lymphokines when stimulated with calcium ionophore and phorbol ester.
    Hagiwara H; Yokota T; Luh J; Lee F; Arai K; Arai N; Zlotnik A
    J Immunol; 1988 Mar; 140(5):1561-5. PubMed ID: 3126229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble factors for B cell activation: a T cell hybridoma that secretes a specific B cell growth factor.
    Garchon HJ; Levi-Strauss M; Carnaud C; Bach JF
    J Immunol; 1983 Feb; 130(2):777-80. PubMed ID: 6600254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen-specific T cells that form IgE-potentiating factor, IgG-potentiating factor, and antigen-specific glycosylation-enhancing factor on antigenic stimulation.
    Iwata M; Adachi M; Ishizaka K
    J Immunol; 1988 Apr; 140(8):2534-42. PubMed ID: 3258613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of interleukin 2 produced from tumor cell lines and T cell hybridomas.
    Gillis S; Mochizuki D
    Curr Top Microbiol Immunol; 1982; 100():211-9. PubMed ID: 6980094
    [No Abstract]   [Full Text] [Related]  

  • 17. Coordinate production by a T cell hybridoma of gamma interferon and three other lymphokine activities: multiple activities of a single lymphokine?
    Zlotnik A; Roberts WK; Vasil A; Blumenthal E; Larosa F; Leibson HJ; Endres RO; Graham SD; White J; Hill J; Henson P; Klein JR; Bevan MJ; Marrack P; Kappler JW
    J Immunol; 1983 Aug; 131(2):794-800. PubMed ID: 6223094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A "panreactive" T cell lines and T cell hybridoma: their function in helping B cells.
    Andersson J; Melchers F; Zeuthen J
    Curr Top Microbiol Immunol; 1982; 100():165-72. PubMed ID: 6980091
    [No Abstract]   [Full Text] [Related]  

  • 19. Production of macrophage activation factor by a T-cell hybridoma.
    Ratliff TL; Thomasson DL; McCool RE; Catalona WJ
    Cell Immunol; 1982 Apr; 68(2):311-21. PubMed ID: 7046954
    [No Abstract]   [Full Text] [Related]  

  • 20. Establishment of T-cell hybridoma constitutively producing macrophage-dependent T-cell replacing factor.
    Nariuchi H; Mizuguchi J; Taira S; Kakiuchi T
    Cell Immunol; 1986 Jan; 97(1):34-43. PubMed ID: 3488824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.